PriceTargets.com logo

Adagio Medical - ADGM Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $4.00
  • Forecasted Upside: 323.28%
  • Number of Analysts: 2
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.95 As of 12/5/2025 12:36 PM ET
▲ +0.0544 (6.11%)

This chart shows the closing price for ADGM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Adagio Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ADGM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ADGM

Analyst Price Target is $4.00
▲ +323.28% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Adagio Medical in the last 3 months. The average price target is $4.00, with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 323.28% upside from the last price of $0.95.

This chart shows the closing price for ADGM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 2 contributing investment analysts is to hold stock in Adagio Medical. This rating changed within the last month from a Sell consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/13/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/11/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/10/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/8/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/6/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
11/5/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
12/5/2025

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/2/2025Lake Street CapitalInitiated CoverageBuy$4.00
12/1/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
11/25/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
10/30/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
10/8/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
9/27/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
(Data available from 12/5/2020 forward)

News Sentiment Rating

-0.10 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/9/2025
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/8/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/8/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/7/2025
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/6/2025
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/6/2025
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/5/2025
  • 0 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2025

Current Sentiment

  • 0 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

  • No very positive mentions tracked during this time.
Adagio Medical logo
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.
Read More

Today's Range

Now: $0.95
Low: $0.91
High: $1.03

50 Day Range

MA: $1.29
Low: $0.77
High: $2.36

52 Week Range

Now: $0.95
Low: $0.63
High: $2.87

Volume

35,838 shs

Average Volume

740,911 shs

Market Capitalization

$14.53 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.16

Frequently Asked Questions

What sell-side analysts currently cover shares of Adagio Medical?

The following Wall Street sell-side analysts have issued research reports on Adagio Medical in the last year: Lake Street Capital, and Weiss Ratings.
View the latest analyst ratings for ADGM.

What is the current price target for Adagio Medical?

0 Wall Street analysts have set twelve-month price targets for Adagio Medical in the last year. Their average twelve-month price target is $4.00, suggesting a possible upside of 349.1%. Lake Street Capital has the highest price target set, predicting ADGM will reach $4.00 in the next twelve months. Lake Street Capital has the lowest price target set, forecasting a price of $4.00 for Adagio Medical in the next year.
View the latest price targets for ADGM.

What is the current consensus analyst rating for Adagio Medical?

Adagio Medical currently has 1 sell rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ADGM, but not buy more shares or sell existing shares.
View the latest ratings for ADGM.

What other companies compete with Adagio Medical?

Other companies that are similar to Adagio Medical include Clipper Realty, Integrated Rail and Resources Acquisition, CoinShares Valkyrie Bitcoin Fund, Global Self Storage and Aimei Health Technology. Learn More about companies similar to Adagio Medical.

How do I contact Adagio Medical's investor relations team?

Adagio Medical's physical mailing address is 26051 Merit Circle, Suite 102, Laguna Hills, CA 92653, United States. The company's listed phone number is (212) 284-2300 and its investor relations email address is [email protected]. The official website for Adagio Medical is adagiomedical.com. Learn More about contacing Adagio Medical investor relations.